Protagonist Therapeutics Inc (PTGX)
Investing Cash Flow
$78.72M
TTM · Period ending: · USD
PTGX Investing Cash Flow
Latest reported$78.72Mperiod ending
Latest reported$78.72Mperiod ending
PTGX TTM Cash from Investing (-$8.26M → $78.72M)
TTM investing cash flow
High-resolution chart · PNG
PTGX investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 78,722,000 | |
| 135,962,000 | |
| -49,332,000 | |
| -106,872,000 | |
| -257,027,000 | |
| -399,956,000 | |
| -299,483,000 | |
| -352,045,000 | |
| -156,894,000 | |
| -43,013,000 | |
| -39,258,000 | |
| 25,964,000 | |
| 96,798,000 | |
| 105,770,000 | |
| 91,468,000 | |
| 115,400,000 | |
| 13,418,000 | |
| -13,543,000 | |
| -15,860,000 | |
| -118,129,000 | |
| -127,544,000 | |
| -140,488,000 | |
| -90,965,000 | |
| -29,117,000 | |
| -7,034,000 | |
| -15,088,000 | |
| -53,710,000 | |
| -36,607,000 | |
| 5,349,000 | |
| 28,165,000 | |
| 2,213,000 | |
| 2,416,000 | |
| -8,273,000 | |
| -4,771,000 | |
| 15,823,000 | |
| -53,254,000 | |
| -48,598,000 | |
| -67,725,000 | |
| -59,328,000 | |
| -3,088,000 | |
| -7,085,000 | |
| -1,112,000 | |
| -8,264,000 |